US 7959925
Trimeric OX40-immunoglobulin fusion protein and methods of use
granted A61KA61K2039/55516A61K38/191
Quick answer
US patent 7959925 (Trimeric OX40-immunoglobulin fusion protein and methods of use) held by Providence Health System expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Providence Health System
- Grant date
- Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/55516, A61K38/191, A61K39/39, A61P